首页|2019-2023年全国≥60岁人群3种非免疫规划疫苗接种情况分析

2019-2023年全国≥60岁人群3种非免疫规划疫苗接种情况分析

扫码查看
目的 了解全国≥60岁人群2019-2023年各流感季流感疫苗、2020-2022年23价肺炎球菌多糖疫苗(23-valent polysaccharide pneumococcal vaccine,PPV23)和重组带状疱疹疫苗(recombinant zoster vac-cine,RZV)的接种情况.方法 使用国家免疫规划信息系统3种疫苗接种个案数据进行描述性分析,并估算全国与各省3种疫苗接种率.结果 2019-2023年各流感季全国≥60岁人群流感疫苗接种率分别为1.57%、3.03%、3.75%、4.16%,前2个流感季估算接种率最高均为北京市(16.06%和18.83%),后2个流感季估算接种率最高为浙江省和西藏自治区(21.39%和48.01%);2020-2022年全国≥60岁人群PPV23接种率分别为2.35%、2.80%、3.23%,3年接种率最高的为上海市;全国≥60岁人群RZV接种率分别为0.01%、0.04%、0.10%,2022年接种率最高的为北京市(0.54%).结论 2019-2023年全国≥60岁人群3种疫苗接种率均呈逐年增加趋势,RZV接种率普遍较低,未来仍有必要针对老年人群采取进一步干预措施提高疫苗接种率.
Vaccination coverage of three non-EPI vaccines among the national population aged ≥60 years from 2019 to 2023
Objective To estimate the coverage of influenza vaccine,23-valent polysaccharide pneumococcal vaccine(PPV23),and recombinant zoster vaccine(RZV)among the national population aged 60 years and older from 2019 to 2023.Methods Descriptive analysis was performed using case data from the National Immunization Program Informa-tion System,and the vaccination coverage rates of the three vaccines were estimated at the national and provincial levels.Results The national vaccination coverage rates of influenza vaccine among the population aged 60 years and older were 1.57%,3.03%,3.75%,and 4.16%in the 2019-2023 influenza seasons,respectively.The highest coverage rates were estimated in Beijing in the first two seasons(16.06%and 18.83%)and in Zhejiang Province and Tibet autonomous region in the last two seasons(21.39%and 48.01%).The national vaccination coverage rates of PPV23 among the population aged ≥60 years were 2.35%,2.80%,and 3.23%from 2020 to 2022,with the highest coverage in Shang-hai.The national vaccination coverage rates of RZV among the population aged ≥60 years were 0.01%,0.04%,and 0.10%from 2020 to 2022,with the highest coverage in Beijing in 2022(0.54%).Conclusions The vaccination cover-age rates of the three vaccines among the national population aged ≥ 60 years showed an increasing trend from 2019 to 2023;however,a gap still exists when compared to developed countries.Rates of recombinant zoster vaccine were gen-erally low,and further interventions targeting the elderly population are necessary.

Influenza vaccinesPneumococcal vaccinesZoster vaccineElderly

程立雪、李力、曹雷、宋祎凡、张肇南、尹遵栋

展开 >

中国疾病预防控制中心免疫规划中心传染病溯源预警与智能决策全国重点实验室,北京 100050

流感疫苗 肺炎球菌疫苗 带状疱疹疫苗 老年人

&&

102393220020010000017

2024

中国预防医学杂志
中华预防医学会

中国预防医学杂志

CSTPCD
影响因子:1.004
ISSN:1009-6639
年,卷(期):2024.25(5)
  • 10